Innovation Practices in Biopharma, MedTech, and Digital Medicine

Authors

  • Arthur A Boni

DOI:

https://doi.org/10.5912/jcb851

Abstract

Section two applies the principles presented and summarized in Section One to the production side of the healthcare industry, and consists of 7 chapters (or contributed articles). Our focus is on biopharma (the converged pharma and biotech segments), MedTech, and digital medicine. We also include a discussion on areas of convergence of technology, healthcare, and biopharma as the broader industry has begun adoption of a customer-centric business model that incorporates solutions that merge drugs, devices, and digital technology to impact the entire healthcare system.

Published

2018-06-12

Issue

Section

Special Section